21-hydroxylase deficiency other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{21-hydroxylase deficiency}} | {{21-hydroxylase deficiency}} | ||
{{CMG}} {{MJ}} | {{CMG}}; {{AE}} {{MJ}} | ||
==Overview== | ==Overview== | ||
Revision as of 16:18, 21 July 2017
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency other diagnostic studies |
|
21-hydroxylase deficiency other diagnostic studies in the news |
|
Risk calculators and risk factors for 21-hydroxylase deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are Amniotic fluid testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies, and utilize fetal DNA extracted from maternal blood through noninvasive methods.
Other Diagnostic Studies
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:
- Amniotic fluid testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies.
- Utilize fetal DNA extracted from maternal blood through noninvasive methods.[1]
References
- ↑ Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). "New developments in prenatal diagnosis of congenital adrenal hyperplasia". J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.